| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.295 | 6.812 | 3.715 | 4.972 | 3.502 | 3.750 | 0 | 0 | 0 |
| Total Income - EUR | - | 1.295 | 6.812 | 3.715 | 4.972 | 3.502 | 3.750 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 4.269 | 6.277 | 6.296 | 7.122 | 4.586 | 3.583 | 202 | 101 | 0 |
| Gross Profit/Loss - EUR | - | -2.974 | 535 | -2.582 | -2.150 | -1.084 | 167 | -202 | -101 | 0 |
| Net Profit/Loss - EUR | - | -3.009 | 330 | -2.693 | -2.299 | -1.189 | 54 | -202 | -101 | 0 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Tecksimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 960 | 1.571 | 1.340 | 698 | 381 | 0 | 0 | 0 | 0 |
| Current Assets | - | 281 | 1.442 | 292 | 524 | 357 | 0 | 0 | 0 | 0 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 223 | 219 | 215 | 312 | 207 | 0 | 0 | 0 | 0 |
| Cash | - | 59 | 1.223 | 77 | 212 | 150 | 0 | 0 | 0 | 0 |
| Shareholders Funds | - | -2.920 | -2.541 | -5.187 | -7.386 | -8.435 | -8.193 | -8.421 | -8.497 | -8.449 |
| Social Capital | - | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | 4.162 | 5.554 | 6.819 | 8.608 | 9.172 | 8.193 | 8.421 | 8.497 | 8.449 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9329 - 9329" | |||||||||
| CAEN Financial Year |
9329
|
|||||||||
Comments - Tecksimed Srl